These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9179635)

  • 1. Mianserin and restless legs.
    Markkula J; Lauerma H
    Int Clin Psychopharmacol; 1997 Jan; 12(1):53-8. PubMed ID: 9179635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mianserin-induced restless legs syndrome.
    Paik IH; Lee C; Choi BM; Chae YL; Kim CE
    Br J Psychiatry; 1989 Sep; 155():415-7. PubMed ID: 2638582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restless legs syndrome induced by mirtazapine.
    Ağargün MY; Kara H; Ozbek H; Tombul T; Ozer OA
    J Clin Psychiatry; 2002 Dec; 63(12):1179. PubMed ID: 12530413
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluoxetine-mirtazapine interaction may induce restless legs syndrome: report of 3 cases from a clinical trial.
    Prospero-Garcia KA; Torres-Ruiz A; Ramirez-Bermudez J; Velazquez-Moctezuma J; Arana-Lechuga Y; Teran-Perez G
    J Clin Psychiatry; 2006 Nov; 67(11):1820. PubMed ID: 17196069
    [No Abstract]   [Full Text] [Related]  

  • 5. Re-administration of mirtazapine could overcome previous mirtazapine- associated restless legs syndrome?
    Pae CU; Kim TS; Kim JJ; Chae JH; Lee CU; Lee SJ; Paik IH; Lee C
    Psychiatry Clin Neurosci; 2004 Dec; 58(6):669-70. PubMed ID: 15601394
    [No Abstract]   [Full Text] [Related]  

  • 6. Mirtazapine-induced restless legs syndrome treated with pramipexole.
    Makiguchi A; Nishida M; Shioda K; Suda S; Nisijima K; Kato S
    J Neuropsychiatry Clin Neurosci; 2015; 27(1):e76. PubMed ID: 25716506
    [No Abstract]   [Full Text] [Related]  

  • 7. [Worsening of autosomal dominant restless legs syndrome after use of mirtazapine: case report].
    Teive HA; de Quadros A; Barros FC; Werneck LC
    Arq Neuropsiquiatr; 2002 Dec; 60(4):1025-9. PubMed ID: 12563401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restless legs syndrome and paroxetine.
    Sanz-Fuentenebro FJ; Huidobro A; Tejadas-Rivas A
    Acta Psychiatr Scand; 1996 Dec; 94(6):482-4. PubMed ID: 9021005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mirtazapine may have the propensity for developing a restless legs syndrome? A case report.
    Bahk WM; Pae CU; Chae JH; Jun TY; Kim KS
    Psychiatry Clin Neurosci; 2002 Apr; 56(2):209-10. PubMed ID: 11952928
    [No Abstract]   [Full Text] [Related]  

  • 10. Mirtazapine and restless leg syndrome: a case report.
    Bonin B; Vandel P; Kantelip JP
    Therapie; 2000; 55(5):655-6. PubMed ID: 11201984
    [No Abstract]   [Full Text] [Related]  

  • 11. Mirtazapine-induced worsening of restless legs syndrome (RLS) and ropinirole-induced psychosis: challenges in management of depression in RLS.
    Chopra A; Pendergrass DS; Bostwick JM
    Psychosomatics; 2011; 52(1):92-4. PubMed ID: 21300203
    [No Abstract]   [Full Text] [Related]  

  • 12. Restless legs syndrome following the combined use of quetiapine and paroxetine.
    Chou KJ; Chen PY; Huang MC
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1139-40. PubMed ID: 20470847
    [No Abstract]   [Full Text] [Related]  

  • 13. Restless legs syndrome associated with the combined use of quetiapine and venlafaxine.
    Michopoulos I; Ferentinos P; Oulis P; Gournellis R
    J Clin Psychopharmacol; 2014 Feb; 34(1):159-61. PubMed ID: 24135842
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinical and polysomnographic comparison of neuroleptic-induced akathisia and the idiopathic restless legs syndrome.
    Walters AS; Hening W; Rubinstein M; Chokroverty S
    Sleep; 1991 Aug; 14(4):339-45. PubMed ID: 1682986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Periodic Limb Movements During Sleep in Restless Legs Syndrome: A Selective Update.
    Fulda S
    Sleep Med Clin; 2015 Sep; 10(3):241-8, xii. PubMed ID: 26329434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced restless legs syndrome.
    Prescrire Int; 2010 Aug; 19(108):164-5. PubMed ID: 20939448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors potentiating the risk of mirtazapine-associated restless legs syndrome.
    Kim SW; Shin IS; Kim JM; Park KH; Youn T; Yoon JS
    Hum Psychopharmacol; 2008 Oct; 23(7):615-20. PubMed ID: 18756499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asenapine-induced restless legs syndrome: differentiation from akathisia.
    McCall WV; Riley MA; Hodges C; McCloud L; Phillips M; Rosenquist PB
    J Clin Sleep Med; 2014 Dec; 10(12):1341-2. PubMed ID: 25325577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does domperidone potentiate mirtazapine-associated restless legs syndrome?
    Chang CC; Shiah IS; Chang HA; Mao WC
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):316-8. PubMed ID: 16309808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actigraphic assessment of periodic leg movements in patients with restless legs syndrome.
    Cippà MA; Baumann CR; Siccoli MM; Bassetti CL; Poryazova R; Werth E
    J Sleep Res; 2013 Oct; 22(5):589-92. PubMed ID: 23530689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.